Bespoke Extracts (BSPK) Free Cash Flow Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) Free Cash Flow Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 39.19% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 68.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.45% |
| Jun 30, 2025 | -28.65% |
| Mar 31, 2025 | 31.51% |
| Nov 30, 2021 | 30.11% |
| Aug 31, 2021 | -30.37% |
| May 31, 2021 | -21.65% |
| Feb 28, 2021 | -54.26% |
| Nov 30, 2020 | -14.40% |
| May 31, 2020 | 33.33% |
| Feb 29, 2020 | -127.38% |
| Nov 30, 2019 | -21.38% |
| Aug 31, 2019 | -73.69% |
| May 31, 2019 | -40.11% |
| Feb 28, 2019 | -23.07% |
| Nov 30, 2018 | -12.73% |
| Aug 31, 2018 | -78.10% |
| May 31, 2018 | -62.70% |
| Feb 28, 2018 | -0.34% |
| Nov 30, 2017 | 29.95% |
| Aug 31, 2017 | -15.25% |